Lindatox
RX_link

Lindatox
fda sheet

Lindatox
msds (material safety sheet)

Lindatox
Synthesis Reference

Lindatox
Molecular Weight

466.951 g/mol

Lindatox
Melting Point

220-224 oC

Lindatox
H2O Solubility

5 mg/mL

Lindatox
State

Solid

Lindatox
LogP

4.004

Lindatox
Dosage Forms

Solution; Spray

Lindatox
Indication

As an ophthalmic it is used for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and selected infective conjunctivitides. As a nasal spray, used for the treatment and management of seasonal allergic rhinitis.

Lindatox
Pharmacology

Loteprednol etabonate (LE) is a "soft" steroid belonging to a unique class of glucocorticoids. LE possesses a metabolically labile 17 beta-chloromethyl ester function which was designed in order to be hydrolyzed to an inactive carboxylic acid moiety. This inactive metabolite is more hydrophilic and is thus readily eliminated from the body. Loteprednol etabonate has good ocular permeation properties and good skin permeation properties similar to "hard" steroids. It is used as a topical agent for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis and iritis.

Lindatox
Absorption

Very limited systemic absorption, but good absorption at the point of delivery.